Cargando…

Calcium-Mediated Control of Polydopamine Film Oxidation and Iron Chelation

The facile preparation of conformal polydopamine (PDA) films on broad classes of materials has prompted extensive research into a wide variety of potential applications for PDA. The constituent molecular species in PDA exhibit diverse chemical moieties, and therefore highly variable properties of PD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klosterman, Luke, Bettinger, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297649/ https://www.ncbi.nlm.nih.gov/pubmed/28025498 http://dx.doi.org/10.3390/ijms18010014

Ejemplares similares

Chelator-Free/Chelator-Mediated Radiolabeling of Colloidally Stabilized Iron Oxide Nanoparticles for Biomedical Imaging
por: Papadopoulou, Sofia, et al.
Publicado: (2021)

Iron-Chelated Polydopamine Decorated Doxorubicin-Loaded Nanodevices for Reactive Oxygen Species Enhanced Cancer Combination Therapy
por: Li, Xu-Jing, et al.
Publicado: (2019)

Oxidation-Induced Degradable Nanogels for Iron Chelation
por: Liu, Zhi, et al.
Publicado: (2016)

Surface radio-mineralisation mediates chelate-free radiolabelling of iron oxide nanoparticles
por: Patrick, P. Stephen, et al.
Publicado: (2019)

Polydopamine-Coated Magnetic Iron Oxide Nanoparticles: From Design to Applications
por: Siciliano, Giulia, et al.
Publicado: (2022)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Electropolymerization of Polydopamine at Electrode-Supported Insulating Mesoporous Films
por: Varol, H. Samet, et al.
Publicado: (2023)

Potential of Food Hydrolyzed Proteins and Peptides to Chelate Iron or Calcium and Enhance their Absorption
por: Walters, Mallory E., et al.
Publicado: (2018)

Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)

Polydopamine Nanoparticles Targeting Ferroptosis Mitigate Intervertebral Disc Degeneration Via Reactive Oxygen Species Depletion, Iron Ions Chelation, and GPX4 Ubiquitination Suppression
por: Yang, Xiao, et al.
Publicado: (2023)

Conservative Iron Chelation for Neuroferritinopathy
por: Marchand, Felix, et al.
Publicado: (2022)

The Chemistry of Polydopamine Film Formation: The Amine-Quinone Interplay
por: Alfieri, Maria Laura, et al.
Publicado: (2018)

Electrosynthesis of polydopamine-ethanolamine films for the development of immunosensing interfaces
por: Almeida, Luís C., et al.
Publicado: (2021)

Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Preventive Therapy of Experimental Colitis with Selected iron Chelators and Anti-oxidants
por: Minaiyan, Mohsen, et al.
Publicado: (2012)

Polydopamine Modified Superparamagnetic Iron Oxide Nanoparticles as Multifunctional Nanocarrier for Targeted Prostate Cancer Treatment
por: Singh, Nimisha, et al.
Publicado: (2019)

Physicochemical and Electrochemical Characterization of Electropolymerized Polydopamine Films: Influence of the Deposition Process
por: Kund, Julian, et al.
Publicado: (2021)

Control of Intermolecular Interactions toward the Production of Free-Standing Interfacial Polydopamine Films
por: Szewczyk, Jakub, et al.
Publicado: (2023)

Iron uptake mediated by the plant-derived chelator nicotianamine in the small intestine
por: Murata, Yoshiko, et al.
Publicado: (2020)

Micro-Structured Polydopamine Films via Pulsed Electrochemical Deposition
por: Lin, Jing, et al.
Publicado: (2019)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

Reversing oncogenic transformation with iron chelation
por: Abdelaal, Gina, et al.
Publicado: (2021)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

Iron Chelators and Exogenic Photosensitizers. Synergy through Oxidative Stress Gene Expression
por: Mrozek-Wilczkiewicz, Anna, et al.
Publicado: (2017)

The Utility of Iron Chelators in the Management of Inflammatory Disorders
por: Lehmann, C., et al.
Publicado: (2015)

Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases
por: Kontoghiorghes, George J., et al.
Publicado: (2020)

Conformational Stability Effect of Polymeric Iron Chelators
por: Qian, Jian, et al.
Publicado: (2019)

The synthesis and properties of mitochondrial targeted iron chelators
por: Cilibrizzi, Agostino, et al.
Publicado: (2022)

Chelators in the Treatment of Iron Accumulation in Parkinson's Disease
por: Mounsey, Ross B., et al.
Publicado: (2012)

Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent
por: Lee, Ji Won, et al.
Publicado: (2013)

Adherence to Iron Chelation Therapy and Its Determinants
por: Sidhu, Sukhmani, et al.
Publicado: (2021)

Calcium chelator BAPTA-AM protects against iron overload-induced chondrocyte mitochondrial dysfunction and cartilage degeneration
por: Jing, Xingzhi, et al.
Publicado: (2021)

Hexamethylenediamine-Mediated Polydopamine Film Deposition: Inhibition by Resorcinol as a Strategy for Mapping Quinone Targeting Mechanisms
por: Alfieri, Maria Laura, et al.
Publicado: (2019)

Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children
por: Lee, J W, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_m9atos1brb17e6htldsuf17lm5